This article addresses the critical question of how the divergent strategies employed by the United States and France have influenced their respective outcomes in combating opioid addiction. Despite the challenge of opioid overuse—a pressing global health crisis that has led to widespread social and personal suffering—the United States and France have pursued markedly different response efforts, leading to noticeable disparities in mortality rates and the overall impact of the crisis. Whereas the United States has escalated its response to a national emergency level, France has approached the issue with a suite of policies and interventions, viewing it as a significant public health concern. By conducting a thorough review of government policies, healthcare system responses, and harm reduction strategies within both contexts, this study argues for the potential benefits of integrating certain aspects of France's approach into the United States' strategy to forge a comprehensive and adaptive response to the evolving opioid crisis.
No takes yet. Share an insight, caveat, or question.
Layla Heitman (2026) studied this question.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: